NAMI vs EVER

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

NAMI

35.4
AI Score
VS
EVER Wins

EVER

41.4
AI Score

Investment Advisor Scores

NAMI

35score
Recommendation
SELL

EVER

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAMI EVER Winner
Revenue 59.06M 692.52M EVER
Net Income -13.49M 99.31M EVER
Net Margin -22.8% 14.3% EVER
Operating Income -14.91M 58.34M EVER
ROE -112.5% 41.7% EVER
ROA -49.1% 30.4% EVER
Total Assets 27.49M 326.91M EVER
Cash 9.19M 171.38M EVER
Current Ratio 1.53 2.94 EVER

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% EVER 1M: -4.1% · 3M: -17.5%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

EVER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.1 · Price: $22.20

Fundamentals Snapshot

Metric NAMI EVER
Market Cap — —
Forward P/E 0.0 7.2
Trailing P/E 0.9 7.1
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.1% 1.0%
Operating Margin -0.1% 0.1%
EPS 1.93 3.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVER is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.